Evidence map›Paper›PMID 32060634›Full record

ArticleJournal of materials science. Materials in medicine2020

Long lasting mucoadhesive membrane based on alginate and chitosan for intravaginal drug delivery.

Fabio Tentor, Giorgia Siccardi, Pasquale Sacco, Danilo Demarchi, Eleonora Marsich, Kristoffer Almdal, Sanjukta Bose Goswami, Anja Boisen

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of materials science. Materials in medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
1.9field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 28 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Fabio TentorDepartment of Health Technology, Technical University of Denmark, Ørsteds Plads 345C, 2800 Kgs., Lyngby, Denmark. fabio.tentor@gmail.com.
Giorgia SiccardiDepartment of Electronics and Telecommunications, Politecnico di Torino, Corso Duca degli Abruzzi, 24, 10129, Torino, Italy.
Pasquale SaccoDepartment of Life Sciences, University of Trieste, via L. Giorgieri 5, I-34127, Trieste, Italy.
Danilo DemarchiDepartment of Electronics and Telecommunications, Politecnico di Torino, Corso Duca degli Abruzzi, 24, 10129, Torino, Italy.
Eleonora MarsichDepartment of Medicine, Surgery and Health Sciences, University of Trieste, Piazza dell'Ospitale 1, I-34129, Trieste, Italy.
Kristoffer AlmdalDepartment of Chemistry, Technical University of Denmark, Kemitorvet 207, 2800 Kgs., Lyngby, Denmark.
Sanjukta Bose GoswamiDepartment of Health Technology, Technical University of Denmark, Ørsteds Plads 345C, 2800 Kgs., Lyngby, Denmark.
Anja BoisenDepartment of Health Technology, Technical University of Denmark, Ørsteds Plads 345C, 2800 Kgs., Lyngby, Denmark.
Ørsted (Denmark) · DKPolytechnic University of Turin · ITTechnical University of Denmark · DKUniversity of Trieste · IT

Funding

Danmarks Grundforskningsfond DNRF122Villum Fonden 9301
6 · The paper itself

Abstract

The intravaginal route of administration can be exploited to treat local diseases and for systemic delivery. In this work, we developed an alginate/chitosan membrane sufficiently stable in a simulated vaginal fluid and able to dissolve over time at a very slow and linear rate. The membrane demonstrated good mechanical properties both in its swollen and dry form. As a study case, we evaluated the viability of this potential drug delivery system for the treatment of bacterial vaginosis, a common disease affecting women in their reproductive age. Metronidazole was effectively included in the alginate/chitosan membrane and its bactericide effect was demonstrated against Staphylococcus aureus and Gardnerella vaginalis, simultaneously showing good biocompatibility with a cervix epithelial cell line. Since this alginate/chitosan membrane is stable in a simulated vaginal environment, is easy to fabricate and can be used for the controlled release of a model drug, it represents a promising drug delivery system for local intravaginal applications.

Indexed as

Administration, IntravaginalDrug Delivery SystemsAdhesivenessAlginatesAnti-Bacterial AgentsBiocompatible MaterialsCervix UteriChitosanCompressive StrengthEpithelial CellsFemaleGardnerella vaginalisHumansHydrogelsKineticsMembranes, ArtificialAlginatesAnti-Bacterial AgentsBiocompatible MaterialsChitosanHydrogelsMembranes, ArtificialMetronidazole

Identifiers

PMID32060634
OpenAlexW3006677167

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.